Trademark Overview
On Tuesday, January 27, 2026, a trademark application was filed for MYPARIVU with the United States Patent and Trademark Office. The USPTO has given the MYPARIVU trademark a serial number of 99616921. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, January 27, 2026. This trademark is owned by MBX Biosciences, Inc.. The MYPARIVU trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment of hypoparathyroidism; pharmaceutical preparations for the treatment of autoimmune, cardiovascular, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular, respiratory, and viral diseases and disorders